Single nucleotide polymorphism (SNPs) in genes associated with type 2 diabetes in genome-wide association studies (GWAS) have been found to regulate the release and functioning of incretin hormones in small-scale experimental studies [2, 3]. This evidence concerns the gene GCG and type 2 diabetes mellitus.